Home » Topics » Disease categories and therapies » Urology

Urology
RSS

DiaMedica initiates phase II study of DM-199 in chronic kidney disease

Dec. 18, 2019

Alnylam presents topline data from ILLUMINATE-A phase III study of lumasiran

Dec. 18, 2019

FDA removes partial clinical hold for multiple-ascending-dose study of RGLS-4326

Dec. 17, 2019

Aurinia reports data from pivotal study of voclosporin in lupus nephritis

Dec. 5, 2019

New macrophage metalloelastase inhibitors discovered at Foresee Pharmaceuticals

Dec. 4, 2019

AstraZeneca identifies new TRPC3 and TRPC6 antagonists

Nov. 28, 2019

Peroxiredoxin-1 as a novel therapeutic target in LPS-induced AKI

Nov. 28, 2019

Muscarinic acetylcholine M3 receptor positive allosteric modulators patented by Nippon Shinyaku

Nov. 27, 2019

Phase III ADVOCATE trial of avacopan in ANCA vasculitis meets primary endpoints

Nov. 26, 2019

CLCA1-TMEM16A-chloride current pathway mediates renal injury in aging and diabetes

Nov. 25, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.